Trial intelligence / Profile preview

Intrathecal midazolam, pethidine, and bupivacaine for elective cesarean section spinal anesthesia

IRCT2014102719145N2Phase 3Completed

Sponsor
Fasa University of Medical Sciences
Start
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of midazolam, pethidine and bupivacaine in postoperative pain and postoperative nausea and vomiting (PONV), sponsored by Fasa University of Medical Sciences. Primary endpoints: Analgesia, Hemodynamic status and 1 more. Started Oct 2014; status: completed.

02

Drugs

midazolampethidinebupivacaine
03

Conditions

postoperative painpostoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on IRCT2014102719145N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014102719145N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call